Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent Influenza Virus Vaccine”

243 trials

Showing 20 of 243 results

Large-scale testing (Phase 3)Study completedNCT05642078
What this trial is testing

Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine

Who this might be right for
Prevention of Influenza
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 2,550
Testing effectiveness (Phase 2)Study completedNCT05734040
What this trial is testing

Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

Who this might be right for
Influenza
Osivax 478
Large-scale testing (Phase 3)Study completedNCT02214225
What this trial is testing

Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.

Who this might be right for
Influenza, Human
Seqirus 3,484
Large-scale testing (Phase 3)Study completedNCT01439360
What this trial is testing

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

Who this might be right for
Influenza
GlaxoSmithKline 12,046
Not applicableStudy completedNCT05568979
What this trial is testing

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

Who this might be right for
Influenza (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 1,001
Large-scale testing (Phase 3)Study completedNCT03165617
What this trial is testing

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age

Who this might be right for
Influenza, Human
Seqirus 4,514
Large-scale testing (Phase 3)Ended earlyNCT04544267
What this trial is testing

Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 100
Testing effectiveness (Phase 2)Study completedNCT04961541
What this trial is testing

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 637
Post-approval studies (Phase 4)Study completedNCT03688620
What this trial is testing

Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season

Who this might be right for
Influenza, Human
GlaxoSmithKline 1,060
Large-scale testing (Phase 3)Study completedNCT01967784
What this trial is testing

Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 100
Testing effectiveness (Phase 2)Study completedNCT05519839
What this trial is testing

Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine

Who this might be right for
COVID-19Influenza
Novavax 1,579
Post-approval studies (Phase 4)Study completedNCT02592486
What this trial is testing

The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine

Who this might be right for
Pneumococcal PneumoniaInfluenza
Kameda Medical Center 162
Large-scale testing (Phase 3)Study completedNCT02369341
What this trial is testing

Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above

Who this might be right for
Influenza
GlaxoSmithKline 121
Testing effectiveness (Phase 2)Study completedNCT03698279
What this trial is testing

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 665
Large-scale testing (Phase 3)Study completedNCT04537234
What this trial is testing

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and Older

Who this might be right for
Influenza (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 165
Large-scale testing (Phase 3)Study completedNCT03859141
What this trial is testing

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 2,340
Testing effectiveness (Phase 2)Study completedNCT05650554
What this trial is testing

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 682
Testing effectiveness (Phase 2)Study completedNCT01974895
What this trial is testing

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age

Who this might be right for
Influenza
GlaxoSmithKline 316
Very early researchStudy completedNCT06831786
What this trial is testing

Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers

Who this might be right for
COVID - 19
Prince of Songkla University 36
Post-approval studies (Phase 4)Study completedNCT05512494
What this trial is testing

Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 1,260
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation